Therapeutic Advances in Endocrinology and Metabolism

Papers
(The H4-Index of Therapeutic Advances in Endocrinology and Metabolism is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis140
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach139
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review70
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity45
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults42
Controversies in the management of active Charcot neuroarthropathy32
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study31
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review29
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system24
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses22
Update on genetics and epigenetics in metabolic associated fatty liver disease22
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers22
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study21
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease21
Is there a causal relationship between hypothyroidism and hyponatremia?20
Pheochromocytoma: a changing perspective and current concepts20
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor19
Using digital tools to improve diabetes care in India with continuous glucose monitoring19
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study18
0.19885396957397